The Effect of the 2019 Reduction in Price of PCSK9 Inhibitors on Total Cost, Out-of-Pocket Cost, and Access among Medicare Part D Beneficiaries
CIRCULATION（2023）
Key words
PCSK9,Health policy,Health economics,Lipids,Health services research
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined